tradingkey.logo
tradingkey.logo
検索

Jupiter Neurosciences Inc

JUNS
ウォッチリストに追加
1.760USD
-0.100-5.38%
終値 11-13 16:00(ET)
2.32M時価総額
損失額直近12ヶ月PER

Jupiter Neurosciences Incについて 企業名

Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Jupiter Neurosciences Inc プロフィール

企業コードJUNS
会社名Jupiter Neurosciences Inc
上場日Dec 03, 2024
最高経営責任者「CEO」Rosen (Christer)
従業員数4
証券種類Ordinary Share
決算期末Dec 03
本社所在地1001 North US HWY 1, Suite 504
都市PALM BEACH GARDENS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号33477
電話番号15614066154
ウェブサイトhttps://jupiterneurosciences.com/
企業コードJUNS
上場日Dec 03, 2024
最高経営責任者「CEO」Rosen (Christer)

Jupiter Neurosciences Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christer Rosen
Mr. Christer Rosen
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
141.06K
-4.70%
Mr. Alexander Gustaf Erik Rosen
Mr. Alexander Gustaf Erik Rosen
Co-Founder, Chief Administrative Officer
Co-Founder, Chief Administrative Officer
6.04K
-36.34%
Ms. Allison W. Brady
Ms. Allison W. Brady
Independent Director
Independent Director
290.00
-358.62%
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Independent Director
Independent Director
144.00
-794.44%
Ms. Alison D. Silva
Ms. Alison D. Silva
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
34.00
-4323.53%
Dr. Marshall A. Hayward, Ph.D.
Dr. Marshall A. Hayward, Ph.D.
Co-Founder, Chief Scientific Officer, Director
Co-Founder, Chief Scientific Officer, Director
--
--
Mr. Nicholas H. Hemmerly
Mr. Nicholas H. Hemmerly
Independent Director
Independent Director
--
-100.00%
Ms. Julie Kampf
Ms. Julie Kampf
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Tomas J. Philipson
Dr. Tomas J. Philipson
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christer Rosen
Mr. Christer Rosen
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
141.06K
-4.70%
Mr. Alexander Gustaf Erik Rosen
Mr. Alexander Gustaf Erik Rosen
Co-Founder, Chief Administrative Officer
Co-Founder, Chief Administrative Officer
6.04K
-36.34%
Ms. Allison W. Brady
Ms. Allison W. Brady
Independent Director
Independent Director
290.00
-358.62%
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Independent Director
Independent Director
144.00
-794.44%
Ms. Alison D. Silva
Ms. Alison D. Silva
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
34.00
-4323.53%
Dr. Marshall A. Hayward, Ph.D.
Dr. Marshall A. Hayward, Ph.D.
Co-Founder, Chief Scientific Officer, Director
Co-Founder, Chief Scientific Officer, Director
--
--

よくある質問

Jupiter Neurosciences Incの上位5名の株主は誰ですか?

Jupiter Neurosciences Incの上位5名の株主は以下のとおりです。Mr. Christer Rosen

Jupiter Neurosciences Inc(JUNS)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Jupiter Neurosciences Incの株式を保有している機関は21社あり、保有株式の総市場価値は約2.06Mで、全体の5.68%を占めています。2025Q4と比較して、機関の持ち株は1545404.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。